美国FDA将审议放宽肽类注射限制
2026-06-21 16:21:18
美国食品药品监督管理局(FDA)今年夏天将考虑放宽对部分肽类注射剂的限制。据 Bloomberg 报道，此举得到小罗伯特·肯尼迪及特朗普政府的推动；相关肽类在健康爱好者和生物黑客中流行。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
《玩具总动员5》创2026年最佳首周末票房Next article：
FDA to Review Easing Restrictions on Peptides
